Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes

Photochemistry and Photobiology

Volumn 88, Issue 3, 2012, Pages 499-511

  Vera, Domingo Mariano Adolfo ^a   Haynes, Mark H ^b   Ball, Anthony R ^c   Dai, Tianhong ^d,e   Astrakas, Christos ^f   Kelso, Michael J ^g   Hamblin, Michael R ^d,e,h   Tegos, George P ^b,d,e,i  

^a UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Toxikon Corporation   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^g UNIVERSITY OF WOLLONGONG   (Australia)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

ⁱ UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

BACTERIUM; BIOFILM; DRUG EFFECT; FUNGUS; HUMAN; METABOLISM; PHOTOCHEMOTHERAPY; REVIEW;

ANTI-INFECTIVE AGENTS; BACTERIA; BIOFILMS; FUNGI; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 84860662140     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01087.x     Document Type: Review

References (127)

1. Binder, S., A. M. Levitt, J. J. Sacks, and, J. M. Hughes, (1999) Emerging infectious diseases: Public health issues for the 21st century. Science 284, 1311-1313.
2. Hamblin, M., and, T. Hasan, (2004) Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436-450.
3. Raab, O., (1900) Ueber diewirkung fluoreszierender stoffe auf infusori. Z. Biol. 39, 524-536.
4. Mitton, D., and, R. Ackroyd, (2008) A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn. Ther. 5, 103-111.
5. St. Denis, T. G., T. Dai, L. Izikson, C. Astrakas, R. R. Anderson, M. R. Hamblin, and, G. P. Tegos, (2011) All you need is light: Antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence 2, 1-12.
6. Hunt, D. W., (2002) Rostaporfin (Miravant Medical Technologies). IDrugs 5, 180-186.
7. Nitzan, Y., M. Gutterman, Z. Malik, and, B. Ehrenberg, (1992) Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem. Photobiol. 55, 89-96.
8. Wainwright, M., M. N. Byrne, and, M. A. Gattrell, (2006) Phenothiazinium-based photobactericidal materials. J. Photochem. Photobiol. B 84, 227-230.
9. Huang, L., Y. Y. Huang, P. Mroz, G. P. Tegos, T. Zhiyentayev, S. K. Sharma, Z. Lu, T. Balasubramanian, M. Krayer, C. Ruzié, E. Yang, H. L. Kee, C. Kirmaier, J. R. Diers, D. F. Bocian, D. Holten, J. S. Lindsey, and, M. R. Hamblin, (2010) Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother. 54, 3834-3841.
10. Castano, A. P., T. N. Demidova, and, M. R. Hamblin, (2004) Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodynam. Ther. 1, 279-293.
11. Schafer, M., C. Schmitz, R. Facius, G. Horneck, B. Milow, K. H. Funken, and, J. Ortner, (2000) Systematic study of parameters influencing the action of Rose Bengal with visible light on bacterial cells: Comparison between the biological effect and singlet-oxygen production. Photochem. Photobiol. 71, 514-523.
12. Kubin, A., F. Wierrani, R. H. Jindra, H. G. Loew, W. Grunberger, R. Ebermann, and, G. Alth, (1999) Antagonistic effects of combination photosensitization by hypericin, meso-tetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus. Drugs Exp. Clin. Res. 25, 13-21.
13. Harris, F., L. K. Chatfield, and, D. A. Phoenix, (2005) Phenothiazinium based photosensitisers-Photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug Targets. 6, 615-627.
14. Tegos, G., T. N. Demidova, D. Arcila-Lopez, H. Lee, T. Wharton, H. Gali, and, M. R. Hamblin, (2005) Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12, 1127-1135.
15. Huang, L., M. Terakawa, T. Zhiyentayev, Y. Y. Huang, Y. Sawayama, A. Jahnke, G. P. Tegos, T. Wharton, and, M. R. Hamblin, (2010) Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine 6, 442-452.
16. Fisher, W., W. P. Partridge Jr., C. Dees, and, E. A. Wachter, (1997) Simultaneous two-photon activation of type-I photodynamic therapy agents. Photochem. Photobiol. 66, 141-155.
17. Alekshun, M., and, S. B. Levy, (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128, 1037-1050.
18. Piddock, L., (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402.
19. Cannon, R. D., E. Lamping, A. R. Holmes, K. Niimi, P. V. Baret, M. V. Keniya, K. Tanabe, M. Niimi, A. Goffeau, and, B. C. Monk, (2009) Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev. 2, 291-321.
20. Paulsen, I. T., J. Chen, K. E. Nelson, and, M. H. J. Saier, (2002) Comparative genomics of microbial drug efflux systems. In Microbial Multidrug Efflux (Edited by, K. Lewis,), pp. 5-21. Horizon Press, Norfolk, UK.
21. Tegos, G. P., (2006) Substrates and Inhibitors of microbial efflux pumps; redefine the role of plant antimicrobials. In Naturally occurring bioactive compounds: a new and safe alternative for control of pests and microbial diseases (Edited by, M. Rai, and, C. Carpinellla,), pp. 45-59. Cambridge University Press, Cambridge.
22. Ren, Q., and, I. T. Paulsen, (2005) Comparative analyses of fundamental differences in membrane transport capabilities in prokaryotes and eukaryotes. PLoS Comput. Biol. 3, e27.
23. Fletcher, J. I., M. Haber, M. J. Henderson, and, M. D. Norris, (2010) ABC transporters in cancer: More than just drug efflux pumps. Nat. Rev. Cancer 10, 147-156.
24. Paumi, C. M., M. Chuck, J. Snider, I. Stagljar, and, S. Michaelis, (2009) ABC transporters in Saccharomyces cerevisiae and their interactors: New technology advances the biology of the ABCC (MRP) subfamily. Microbiol. Mol. Biol. Rev. 73, 577-593.
25. Lister, P., D. J. Wolter, and, N. D. Hanson, (2009) Antibacterial- resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582-610.
26. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, R. Goltry, E. Tolentino, S. Westbrock-Wadman, and, Y. Yuan, (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959-964.
27. Yin, Y., X. He, P. Szewczyk, T. Nguyen, and, G. Chang, (2006) Structure of the multidrug transporter EmrD from Escherichia coli. Science 312, 741-744.
28. Huang, Y., M. J. Lemieux, J. Song, M. Auer, and, D. N. Wang, (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301, 616-620.
29. Aller, S., J. Yu, A. Ward, Y. Weng, S. Chittaboina, R. Zhuo, P. Harrell, Y. T. Trinh, Q. Zhang, I. L. Urbatsch, and, G. Chang, (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718-1722.
30. Koronakis, V., A. Sharff, E. Koronakis, B. Luisi, and, C. Hughes, (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914-919.
31. Sennhauser, G., M. A. Bukowska, C. Briand, and, M. G. Grütter, (2009) Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 389, 134-145.
32. Phan, G., H. Benabdelhak, M. B. Lascombe, P. Benas, S. Rety, M. Picard, A. Ducruix, C. Etchebest, and, I. Broutin, (2010) Structural and dynamical insights into the opening mechanism of P. aeruginosa OprM channel. Structure 18, 507-517.
33. Akama, H., T. Matsuura, S. Kashiwagi, H. Yoneyama, S. Narita, T. Tsukihara, A. Nakagawa, and, T. Nakae, (2004) Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279, 25939-25942.
34. Yum, S., Y. Xu, S. Piao, S. H. Sim, H. M. Kim, W. S. Jo, K. J. Kim, H. S. Kweon, M. H. Jeong, H. Jeon, K. Lee, and, N. C. Ha, (2009) Crystal structure of the periplasmic component of a tripartite macrolide-specific efflux pump. J. Mol. Biol. 387, 1286-1297.
35. He, X., P. Szewczyk, A. Karyakin, M. Evin, W. X. Hong, Q. Zhang, and, G. Chang, (2010) Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature 467, 991-994.
36. Robey, R., K. Steadman, O. Polgar, and, S. E. Bates, (2005) ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy. Cancer Biol. Ther. 4, 187-194.
37. Robey, R., P. A. Fetsch, O. Polgar, M. Dean, and, S. E. Bates, (2006) The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2. Res. Vet. Sci. 81, 345-349.
38. Ogino, T., H. Kobuchi, K. Munetomo, H. Fujita, M. Yamamoto, T. Utsumi, K. Inoue, T. Shuin, J. Sasaki, M. Inoue, and, K. Utsumi, (2011) Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells. Mol. Cell. Biochem. 358, 297-307.
39. Morgan, J., J. D. Jackson, X. Zheng, S. K. Pandey, and, R. K. Pandey, (2010) Substrate affinity of photosensitizers derived from chlorophyll-A: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol. Pharm. [Epub ahead of print].
40. Jendzelovskã, R., J. Mikes, J. Koval, K. Soucek, J. Procházková, M. Kello, V. Sacková, J. Hofmanová, A. Kozubík, and, P. Fedorocko, (2009) Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Photochem. Photobiol. Sci. 8, 1716-1723.
41. Merlin, J., H. Gautier, M. Barberi-Heyob, M. H. Teiten, and, F. Guillemin, (2003) The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells. Int. J. Oncol. 22, 733-739.
42. Wang, E., C. N. Casciano, R. P. Clement, and, W. W. Johnson, (2001) Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm. Res. 18, 432-438.
43. Adigbli, D., D. G. Wilson, N. Farooqui, E. Sousi, P. Risley, I. Taylor, A. J. Macrobert, and, M. Loizidou, (2007) Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells. Br. J. Cancer 97, 502-512.
44. Stermitz, F., P. Lorenz, J. N. Tawara, L. A. Zenewicz, and, K. Lewis, (2000) Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl Acad. Sci. USA 97, 1433-1437.
45. Tegos, G., F. R. Stermitz, O. Lomovskaya, and, K. Lewis, (2002) Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46, 3133-3141.
46. Tegos, G., and, M. R. Hamblin, (2006) Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob. Agents Chemother. 50, 196-203.
47. Tseng, S. P., L. J. Teng, C. T. Chen, T. H. Lo, W. H. Hung, H. J. Chen, P. R. Hsueh, and, J. C. Tsai, (2009) Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg. Med. 41, 391-397.
48. Prates, R., I. T. Kato, M. S. Ribeiro, G. P. Tegos, and, M. R. Hamblin, (2011) Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J. Antimicrob. Chemother. 66, 1525-1532.
49. Sabatini, S., G. W. Kaatz, G. M. Rossolini, D. Brandini, and, A. Fravolini, (2008) From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. J. Med. Chem. 51, 4321-4330.
50. Amaral, L., M. Martins, M. Viveiros, J. Molnar, and, J. E. Kristiansen, (2008) Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps. Curr. Drug Targets 9, 816-819.
51. Bailey, A., I. T. Paulsen, and, L. J. Piddock, (2008) RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob. Agents Chemother. 10, 3604-3611.
52. Dutta, N., S. Mehra, and, D. Kaushal, (2010) A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. PLoS ONE 5, e10069.
53. Tatsumi, R., and, M. Wachi, (2008) TolC-dependent exclusion of porphyrins in Escherichia coli. J. Bacteriol. 190, 6228-6233.
54. Fernandez, A., D. Lechardeur, A. Derré-Bobillot, E. Couvé, P. Gaudu, and, A. Gruss, (2010) Two coregulated efflux transporters modulate intracellular heme and protoporphyrin IX availability in Streptococcus agalactiae. PLoS Pathog 6, e1000860.
55. Grinholc, M., J. Zawacka-Pankau, A. Gwizdek-WiÅniewska, and, K. P. Bielawski, (2010) Evaluation of the role of the pharmacological inhibition of Staphylococcus aureus multidrug resistance pumps and the variable levels of the uptake of the sensitizer in the strain-dependent response of Staphylococcus aureus to PPArg(2)-based photodynamic inactivation. Photochem. Photobiol. 86, 1118-1126.
56. Gutmann, D., A. Ward, I. L. Urbatsch, G. Chang, and, H. W. van Veen, (2010) Understanding polyspecificity of multidrug ABC transporters: Closing in on the gaps in ABCB1. Trends Biochem. Sci. 35, 36-42.
57. Tegos, G., M. Haynes, J. J. Strouse, M. M. Khan, M. M. T. Khan, C. G. Bologa, T. I. Oprea, and, L. A. Sklar, (2011) Microbial efflux inhibition: Tactics and strategies. Curr. Pharm. Des. 17, 1291-1302.
58. Tegos, G., K. Masago, F. Aziz, A. Higginbotham, F. R. Stermitz, and, M. R. Hamblin, (2008) Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob. Agents Chemother. 52, 3202-3209.
59. Bornstein, E., W. Hermans, S. Gridley, and, J. Manni, (2009) Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem. Photobiol. 85, 1364-1374.
60. Bornstein, E., S. Gridley, P. Wengender, and, A. Robbins, (2010) Photodamage to multidrug-resistant gram-positive and gram-negative bacteria by 870 nm/930 nm light potentiates erythromycin, tetracycline and ciprofloxacin. Photochem. Photobiol. 86, 617-627.
61. Kohanski, M., D. J. Dwyer, B. Hayete, C. A. Lawrence, and, J. J. Collins, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810.
62. Kohanski, M., D. J. Dwyer, J. Wierzbowski, G. Cottarel, and, J. J. Collins, (2008) Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135, 679-690.
63. Tavares, A., C. M. Carvalho, M. A. Faustino, M. G. Neves, J. P. Tomé, A. C. Tomé, J. A. Cavaleiro, A. Cunha, N. C. Gomes, E. Alves, and, A. Almeida, (2010) Antimicrobial photodynamic therapy: Study of bacterial recovery viability and potential development of resistance after treatment. Mar. Drugs 8, 91-105.
64. Giuliani, F., M. Martinelli, A. Cocchi, D. Arbia, L. Fantetti, and, G. Roncucci, (2010) In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob. Agents Chemother. 54, 637-642.
65. Nakonieczna, J., E. Michta, M. Rybicka, M. Grinholc, A. Gwizdek-WiÅniewska, and, K. P. Bielawski, (2010) Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol. 10, 323.
66. Brombacher, K., B. B. Fischer, K. Rüfenacht, and, R. I. Eggen, (2006) The role of Yap1p and Skn7p-mediated oxidative stress response in the defence of Saccharomyces cerevisiae against singlet oxygen. Yeast 23, 741-750.
67. Klyachko, K., S. Schuldiner, and, A. A. Neyfakh, (1997) Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J. Bacteriol. 179, 2189-2193.
68. Ahmed, M., C. Borsch, A. Neyfakh, and, S. Schuldner, (1993) Mutants of Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268, 11086-11089.
69. Garvey, M., and, L. J. Piddock, (2008) The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob. Agents Chemother. 52, 1677-1685.
70. Ball, A., G. Casadei, S. Samosorn, J. B. Bremner, F. M. Ausubel, T. I. Moy, and, K. Lewis, (2006) Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS Chem. Biol. 1, 594-600.
71. Samosorn, S., B. Tanwirat, N. Muhamad, G. Casadei, D. Tomkiewicz, K. Lewis, A. Suksamrarn, T. Prammananan, K. C. Gornall, J. L. Beck, and, J. B. Bremner, (2009) Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg. Med. Chem. 17, 3866-3872.
72. Tomkiewicz, D., G. Casadei, J. Larkins-Ford, T. I. Moy, J. Garner, J. B. Bremner, F. M. Ausubel, K. Lewis, and, M. J. Kelso, (2010) Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: Effects of varying the relative orientation of the berberine and INF55 components. Antimicrob. Agents Chemother. 54, 3219-3224.
73. Costerton, J. W., P. S. Stewart, and, E. P. Greenberg, (1999) Bacterial biofilms: A common cause of persistent infections. Science 284, 1318-1322.
74. Del Pozo, J., and, R. Patel, (2007) The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 82, 204-209.
75. Lewis, K., (2001) Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999-1007.
76. Fontana, C. R., A. D. Abernethy, S. Som, K. Ruggiero, S. Doucette, R. C. Marcantonio, C. I. Boussios, R. Kent, J. M. Goodson, A. C. Tanner, and, N. S. Soukos, (2009) The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J. Periodontal Res. 44, 751-759.
77. Raghavendra, M., A. Koregol, and, S. Bhola, (2009) Photodynamic therapy: A targeted therapy in periodontics. Aust. Dent. J. 54 (Suppl 1), S102-S109.
78. Soukos, N., P. S. Chen, J. T. Morris, K. Ruggiero, A. D. Abernethy, S. Som, F. Foschi, S. Doucette, L. L. Bammann, C. R. Fontana, A. G. Doukas, and, P. P. Stashenko, (2006) Photodynamic therapy for endodontic disinfection. J. Endod. 32, 979-984.
79. Bisland, S., C. Chien, B. C. Wilson, and, S. Burch, (2006) Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem. Photobiol. Sci. 5, 31-38.
80. Donnelly, R., P. A. McCarron, C. M. Cassidy, J. S. Elborn, and, M. M. Tunney, (2007) Delivery of photosensitisers and light through mucus: Investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. J. Control Release 117, 217-226.
81. Schuckert, K., S. Jopp, and, U. Muller, (2006) De novo grown bone on exposed implant surfaces using photodynamic therapy and recombinant human bone morphogenetic protein-2: Case report. Implant Dent. 15, 361-365.
82. Donnelly, R., P. A. McCarron, M. M. Tunney, and, A. David Woolfson, (2007) Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J. Photochem. Photobiol. B 86, 59-69.
83. Dörtbudak, O., R. Haas, T. Bernhart, and, G. Mailath-Pokorny, (2001) Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin. Oral Implants Res. 12, 104-108.
84. Walters, M. C. 3rd, F. Roe, A. Bugnicourt, M. J. Franklin, and, P. S. Stewart, (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47, 317-323.
85. Leid, J. G., M. E. Shirtliff, J. W. Costerton, and, A. P. Stoodley, (2002) Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70, 6339-6345.
86. Jesaitis, A. J., M. J. Franklin, D. Berglund, M. Sasaki, C. I. Lord, J. B. Bleazard, J. E. Duffy, H. Beyenal, and, Z. Lewandowski, (2003) Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J. Immunol. 171, 4329-4339.
87. Vuong, C., J. M. Voyich, E. R. Fischer, K. R. Braughton, A. R. Whitney, F. R. DeLeo, and, M. Otto, (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 6, 269-275.
88. Biel, M., (2010) Photodynamic therapy of bacterial and fungal biofilm infections. Methods Mol. Biol. 635, 175-194.
89. Schneider, M., G. Kirfel, M. Berthold, M. Frentzen, F. Krause, and, A. Braun, (2011) The impact of antimicrobial photodynamic therapy in an artificial biofilm model. Lasers Med. Sci. [Epub ahead of print].
90. Fimple, J., C. R. Fontana, F. Foschi, K. Ruggiero, X. Song, T. C. Pagonis, A. C. Tanner, R. Kent, A. G. Doukas, P. P. Stashenko, and, N. C. Soukos, (2008) Photodynamic treatment of endodontic polymicrobial infection in vitro. J. Endod. 34, 728-734.
91. Gad, F., T. Zahra, T. Hasan, and, M. R. Hamblin, (2004) Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 48, 2173-2178.
92. Sharma, M., L. Visai, F. Bragheri, I. Cristiani, P. K. Gupta, and, P. Speziale, (2008) Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob. Agents Chemother. 52, 299-305.
93. Lin, H., C. T. Chen, and, C. T. Huang, (2004) Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells. Appl. Environ. Microbiol. 70, 6453-6458.
94. Sbarra, M., A. Di Poto, C. R. Arciola, E. Saino, M. Sharma, F. Bragheri, I. Cristiani, P. Speziale, and, L. Visai, (2008) Photodynamic action of merocyanine 540 on Staphylococcus epidermidis biofilms. Int. J. Artif. Organs 31, 848-857.
95. Saino, E., M. S. Sbarra, C. R. Arciola, M. Scavone, N. Bloise, P. Nikolov, F. Ricchelli, and, L. Visai, (2010) Photodynamic action of Tri-meso (N-methyl-pyridyl), meso (N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy. Int. J. Artif. Organs 33, 636-645.
96. Zanin, I., R. B. Gonçalves, A. B. Junior, C. K. Hope, and, J. Pratten, (2005) Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: An in vitro study. J. Antimicrob. Chemother. 56, 324-330.
97. Zanin, I., M. M. Lobo, L. K. Rodrigues, L. A. Pimenta, J. F. Höfling, and, R. B. Gonçalves, (2006) Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur. J. Oral Sci. 114, 64-69.
98. Wood, S., D. Metcalf, D. Devine, and, C. Robinson, (2006) Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother. 57, 680-684.
99. Metcalf, D., C. Robinson, D. Devine, and, S. Wood, (2006) Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J. Antimicrob. Chemother. 58, 190-192.
100. Goulart Rde, C., M. Bolean, P. Paulino Tde, G. Thedei Jr., S. L. Souza, A. C. Tedesco, and, P. Ciancaglini, (2010) Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomycetemcomitans. Photomed. Laser Surg. 28 (1), S53-S60.
101. Nastri, L., G. Donnarumma, C. Porzio, V. De Gregorio, M. A. Tufano, F. Caruso, C. Mazza, and, R. Serpico, (2010) Effects of toluidine blue-mediated photodynamic therapy on periopathogens and periodontal biofilm: In vitro evaluation. Int. J. Immunopathol. Pharmacol. 23, 1125-1132.
102. Lee, C., C. J. Lee, C. T. Chen, and, C. T. Huang, (2004) delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J. Photochem. Photobiol. B 75, 21-25.
103. Collins, T., E. A. Markus, D. J. Hassett, and, J. B. Robinson, (2006) The effect of a cationic porphyrin on Pseudomonas aeruginosa biofilms. Curr. Microbiol. 61, 411-416.
104. Pflumm, M., (2011) Caught on film. Nature Med. 17, 650-653.
105. Hamblin, M. R., J. Viveiros, C. Yang, A. Ahmadi, R. A. Ganz, and, M. J. Tolkoff, (2005) Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob. Agents Chemother. 49, 2822-2827.
106. Ganz, R. A., J. Viveiros, A. Ahmad, A. Ahmadi, A. Khalil, M. J. Tolkoff, N. S. Nishioka, and, M. R. Hamblin, (2005) Helicobacter pylori in patients can be killed by visible light. Lasers Surg. Med. 36, 260-265.
107. Spoering, A. L., and, K. Lewis, (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183, 6746-6751.
108. Tanaka, M., M. Kinoshita, Y. Yoshihara, N. Shinomiya, S. Seki, K. Nemoto, M. R. Hamblin, and, Y. Morimoto, (2011) Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: Biphasic light dose response for neutrophil-mediated antibacterial effect. Lasers Surg. Med. 43, 221-229.
109. Lu, Z., T. Dai, L. Huang, D. B. Kurup, G. P. Tegos, A. Jahnke, T. Wharton, and, M. R. Hamblin, (2010) Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.) 5, 1525-1533.
110. Di Poto, A., M. S. Sbarra, G. Provenza, L. Visai, and, P. Speziale, (2009) The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 30, 3158-3166.
111. Sbarra, M., C. R. Arciola, A. Di Poto, E. Saino, H. Rohde, P. Speziale, and, L. Visai, (2009) The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms. Int. J. Artif. Organs 32, 574-583.
112. Tubby, S., M. Wilson, and, S. P. Nair, (2009) Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC Microbiol. 9, 211.
113. Kömerik, N., M. Wilson, and, S. Poole, (2000) The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem. Photobiol. 72, 676-680.
114. Braham, P., C. Herron, C. Street, and, R. Darveau, (2009) Antimicrobial photodynamic therapy may promote periodontal healing through multiple mechanisms. J. Periodontol. 80, 1790-1798.
115. Waters, C. M., and, B. L. Bassler, (2005) Quorum sensing: Cell-to-cell communication in bacteria. Annu. Rev. Cell Dev. Biol. 21, 319-346.
116. Pearson, J. P., C. Van Delden, and, B. H. Iglewski, (1999) Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181, 1203-1210.
117. Xavier, J., (2011) Social interaction in synthetic and natural microbial communities. Mol. Syst. Biol. 7, 483.
118. Dutta, S., B. G. Ongarora, H. Li, G. Vicente Mda, B. K. Kolli, and, K. P. Chang, (2011) Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine. PLoS ONE 6, e20786.
119. Tegos, G., M. Anbe, C. Yang, T. N. Demidova, M. Satti, P. Mroz, S. Janjua, F. Gad, and, M. R. Hamblin, (2006) Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob. Agents Chemother. 50, 1402-1410.
120. Kishen, A., M. Upadya, G. P. Tegos, and, M. R. Hamblin, (2010) Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm. Photochem. Photobiol. 86, 1343-1349.
121. Huang, L., T. Dai, Y. Xuan, G. P. Tegos, and, M. R. Hamblin, (2011) Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: Efficacy against bacterial burn infections. Antimicrob. Agents Chemother. 55, 3432-3438.
122. Bremner, J., and, M. J. Kelso, (2010) Synthesis of berberine-efflux pump inhibitor hybrid antibacterials. Synth. Commun. 40, 3561-3568.
123. Ambrus, J. I., M. J. Kelso, J. B. Bremner, A. R. Ball, G. Casadei, and, K. Lewis, (2008) Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. Bioorg. Med. Chem. Lett. 18, 4294-4297.
124. Hubschwerien, C., J. Specklin, D. Baseschilin, Y. Borer, S. Haefeli, C. Sigwalt, S. Schroeder, and, H. H. Locher, (2003) Structure-activity relationship in the oxazolidinone-quinolone hybrid series: Influence of the central spacer on the antibacterial activity and the mode of action. Bioorg. Med. Chem. Lett. 13, 4229-4233.
125. Frisch, M. J. T., G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and, J. A. Pople, (2004) Gaussian 03, Revision C.02. Gaussian, Inc., Wallingford, CT.
126. Mennucci, B., and, J. Tomasi, (1997) Continuum solvation models: A new approach to the problem of solute's charge distribution and cavity boundaries. J. Chem. Phys. 106, 5151-5158.
127. Bayly, C., P. Cieplak, W. Cornell, and, P. A. Kollman, (1993) A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J. Phys. Chem. 97, 10269-10280.